QQ客服 官方微博 反馈留言

	The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis
	Gao, Nannan; Zhang, Tengyue; Ji, Jiadong; Xu, Kai-Feng; Tian, Xinlun
刊名	ORPHANET JOURNAL OF RARE DISEASES
	2018
卷号	13
关键词	Lymphangioleiomyomatosis mTOR inhibitors Meta-analysis
DOI	10.1186/s13023-018-0874-7
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4565714
专题	山东大学
作者单位	Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp Med, Beij
推荐引用方式 GB/T 7714	Gao, Nannan,Zhang, Tengyue,Ji, Jiadong,et al. The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis[J]. ORPHANET JOURNAL OF RARE DISEASES,2018,13.
APA	Gao, Nannan,Zhang, Tengyue,Ji, Jiadong,Xu, Kai-Feng,&Tian, Xinlun.(2018).The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis.ORPHANET JOURNAL OF RARE DISEASES,13.
MLA	Gao, Nannan,et al."The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis".ORPHANET JOURNAL OF RARE DISEASES 13(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。